Home  »  Markets   »  Protalix BioTherapeutics Inc. (PLX) Review –...

Protalix BioTherapeutics Inc. (PLX) Review – Making Smarter Decisions

Protalix BioTherapeutics Inc. (AMEX: PLX) is 40.68% higher on its value in year-to-date trading and has touched a low of $0.70 and a high of $2.00 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PLX stock was last observed hovering at around $1.11 in the last trading session, with the day’s gains setting it 0.06%.

Currently trading at $1.17, the stock is 12.51% and 11.73% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.23 million and changing 5.41% at the moment leaves the stock 8.04% off its SMA200. PLX registered 24.14% gain for a year compared to 6-month loss of 8.33%.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


The stock witnessed a 14.71% gain in the last 1 month and extending the period to 3 months gives it a 0.00%, and is 10.38% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.98% over the week and 3.74% over the month.

Protalix BioTherapeutics Inc. (PLX) has around 202 employees, a market worth around $59.28M and $47.57M in sales. Fwd P/E is 7.31. Distance from 52-week low is 67.14% and -41.50% from its 52-week high.

Protalix BioTherapeutics Inc. (PLX) Analyst Forecasts

The EPS is expected to grow by 37.10% this year

Protalix BioTherapeutics Inc. (PLX) Top Institutional Holders

The shares outstanding are 50.67M, and float is at 41.75M with Short Float at 3.99%.

Protalix BioTherapeutics Inc. (PLX) Insider Activity

A total of 0 insider transactions have happened at Protalix BioTherapeutics Inc. (PLX) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider purchase by Bashan Dror, the company’s President and CEO. SEC filings show that Bashan Dror bought 68,000 shares of the company’s common stock on Apr 11 at a price of $1.50 per share for a total of $0.1 million. Following the purchase, the insider now owns 68000.0 shares.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.